
Senate Majority Leader Chuck Schumer, D-New York, said Monday that the Senate would get a second chance at passing a plan to cap insulin prices for non-Medicare patients at $35. Voted to block the provisionYou can be included in the Inflation Reduction Act.
“[Republicans] blocked a $35 price for insulin for non-Medicare people,” Schumer told MSNBC’s Rachel Maddow, after noting that Republicans are “intransigent.”
“We’re going to come back and make them vote on that again,” he went on. “When they get taken over by the extremes — whether on issues of democracy or issues of making people’s lives better and reducing their costs — they’re going to lose out.”
Schumer added that he thinks Republicans’ extremism will “backfire on them” in the midterm elections this fall.
Earlier in the week, Senate Republicans voted against including the insulin cap plan within the IRA. The provision, which Aufgrund of arcane Senate Rules, it required 60 votes to pass, was defeated by 57 votes to 43. Only seven GOP members voted in favor of the measure.
Republicans faced heavy criticism for the voteIncluding from Democrats Who called? the vote “shameful.” In an attempt to stave off scrutiny, Sen. Chuck Grassley (R-Iowa) even attempted to mislead his followers on Twitter, implying that he voted for the provision’s inclusion even though he didn’t.
The plan, a version which the House passed earlier this yearIt would have made insulin more affordable for millions of Americans who depend on it to survive. It would reduce the skyrocketing insulin prices that insurance and pharmaceutical companies impose on diabetics, many of whom are not well-regulated. Report strugglingIt is difficult to afford the medication. The public is open to the idea of limiting insulin’s price; polls show that the majority of respondents are in favor of this proposal. vast majority ofVoters support this plan with over 85 percent of Republicans as well as Democrats saying that they favor the $35 cap.
The flurry of criticism Republicans received for voting against the plan could help it pass if Schumer does bring it back to a vote, as Republicans did in a similar situation last year.
In July Senate Republicans blockedThe passage of the PACT Act, a bill that aimed to provide health coverage for veterans who were exposed to toxic chemical burn pits while in service, was a major victory. Advocates and veterans groups for the bill stated that the legislation was a breakthrough, and could help save thousands from rare and deadly diseases caused by burn pit exposure.
Only five Republicans voted “yes,” leaving the bill short of the votes needed to overcome the 60-vote filibuster. Party members cited false budgetary reasons to justify the vote that took place an hour after Democrats announced their IRA. After being criticized by prominent figures, including Jon Stewart, Republicans eventually reneged on the bill. passed last weekUnchanged, in an overall vote of 86 to 11.
The insulin cap could be in a similar situation. Though Republicans have largely ignored polls showing support for the insulin cap, large swath of proposals they’ve shot down in the past few years, the deluge of bad press could be enough for them to change their minds. Early analyses of polls conducted on this year’s midterm elections have found that Republicans are losing support among voters, and some prognosticators are saying that the election may not be the slam dunk for the GOP that Past trends suggestIt will.
While passing the insulin cap would be great for Democrats and the Republicans, large portionPatients with diabetes who pay more than $35 for insulin per month could see the vote as a reminder of the evils of the Republican party. If GOP senators vote against it again, they could also be used to show the depravity in the Republican party. Schumer confirmed on NPR on Monday that he’s planning to bring the provision to a vote before the midterms this fall, saying, “there’s going to be huge heat on Republicans.”
